HOME >> MEDICINE >> NEWS
Answers To Access, Adherence And Tolerance Of Protease Inhibitors

PROVIDENCE, R.I. - Protease inhibitors - the backbone ingredient of the potent triple therapy drug regimen - may not be performing as well in practice as they did in clinical trials, and some patients who could benefit from them may not be receiving them, according to three studies about access, adherence and tolerance of the potent drugs in 254 patients being treated at five urban sites in Boston and Rhode Island.

In one study, about 40 percent of 151 patients who tried one or more of the four available protease inhibitors eventually discontinued the drug. The most common reason patients gave was gastrointestinal and systemic side effects, followed by treatment failure, says lead author Valerie Stone, M.D., director of the Hope Center for HIV Care at Memorial Hospital in Pawtucket, R.I., and an assistant professor of medicine at Brown University.

"Patients can only benefit from protease inhibitors while they are taking the pills," Stone says. "If it turns out that regular patients in clinical practice aren't able to stick with the medications, they can't derive the benefits, such as increased survival and improved quality of life, that we've been led to expect." The take-home lesson is to optimize treatment regimens for individual patients and to closely manage side effects and toxicity, Stone says.

Despite the side effects and complex daily drug doses, most patients successfully adhere to their protease inhibitor therapy, except for those patients who have active substance abuse or alcohol problems, says another study Stone will present Wednesday, July 1.

Although they can stick to treatment, women, minorities and patients with less education are less likely to be offered potent drug cocktails containing protease inhibitors, according to another paper by Stone and colleagues to be given Thursday, July 2. "While combination regimens containing protease inhibitors can dramatically improve outcomes, not all patients who can benefit are receiving them
'"/>

Contact: Carol Cruzan Morton
carol_morton@brown.edu
401.863.2476
Brown University
30-Jun-1998


Page: 1 2

Related medicine news :

1. X-Rays: How Big A Risk To Kids? UF Researchers Seek Answers
2. Study Shows Child Health Plus Eases Access, But Some Barriers Remain
3. Tolerance for alcohol associated with family history
4. Teen Line Panel Of Six High School Students To Address The Issue Of Teens And Tolerance
5. Protease inhibitor could help prevent alzheimers
6. New Protease Inhibitor Could Thwart AIDS Resistance To Current Drugs
7. HIV Patients Treated With Protease Inhibitors Are More Likely To Engage In Risky Sex, Emory Researchers Report
8. Only Eight Percent Of San Francisco HIV-Positive Urban Poor Receive Protease Inhibitors
9. Declining National Rates Of HIV-Related Deaths And Illnesses Due To Combination Antiretroviral Therapy With Protease Inhibitors
10. Inhibitors prevent aggresome formation associated with some forms of ALS
11. Acetylcholinesterase Inhibitors May Be Another Piece In Alzheimers Jigsaw

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare product ... training aide "cprCUBE" on Kickstarter. The device will educate ... cardiac arrests with better efficiency compared to the dated ... real-time feedback on efficacy of the compression for a ... has a goal to raise $5,000. ...
Breaking Medicine Technology:
Cached News: